New Medicines for Treating Inflammatory Bowel Disease (IBD)
Monday, March 9, 2026
The therapeutic landscape for moderately to severely active inflammatory bowel disease (IBD) has expanded significantly. It incorporates three novel mechanisms of action: Anti-interleukins, JAK inhibitors, and S1P receptor modulators. …
